reference/3648143

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3648143

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article
endingPage	41
issn	0273-8481 1534-5939
issueIdentifier	1
pageRange	37-41
publicationName	The Journal of Burn Care & Rehabilitation
startingPage	37
bibliographicCitation	Acikel C, Oncul O, Ulkur E, Bayram I, Celikoz B, Cavuslu S. Comparison of silver sulfadiazine 1%, mupirocin 2%, and fusidic acid 2% for topical antibacterial effect in methicillin-resistant staphylococci-infected, full-skin thickness rat burn wounds. J Burn Care Rehabil. 2003 Jan;24(1):37–41. doi: 10.1097/00004630-200301000-00008. PMID: 12543989.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4259da0c93b93a0b266ea1c30fa864c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3a190f8567465748ca53bde5a4269b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0fccc0656b686e56c9402872e432ee5a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75826ac8667858605ccd172e96d48e37 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bdfb5c5db799ee94c81ad1324d8a4ec9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6a4da3bff9158ff835b00dbd9147936
date	2003-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1097/00004630-200301000-00008 https://pubmed.ncbi.nlm.nih.gov/12543989
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4576 https://portal.issn.org/resource/ISSN/1534-5939 https://portal.issn.org/resource/ISSN/0273-8481
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Comparison of Silver Sulfadiazine 1%, Mupirocin 2%, and Fusidic Acid 2% for Topical Antibacterial Effect in Methicillin-Resistant Staphylococci-Infected, Full-Skin Thickness Rat Burn Wounds
discusses	http://id.nlm.nih.gov/mesh/M0019872 http://id.nlm.nih.gov/mesh/M0008910 http://id.nlm.nih.gov/mesh/M0025454 http://id.nlm.nih.gov/mesh/M0001330
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000891Q000627 http://id.nlm.nih.gov/mesh/D013203Q000188 http://id.nlm.nih.gov/mesh/D013203Q000209 http://id.nlm.nih.gov/mesh/D012837Q000627 http://id.nlm.nih.gov/mesh/D002056Q000188 http://id.nlm.nih.gov/mesh/D016106 http://id.nlm.nih.gov/mesh/D005672Q000627 http://id.nlm.nih.gov/mesh/D002056Q000150 http://id.nlm.nih.gov/mesh/D016712Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D017208 http://id.nlm.nih.gov/mesh/D004195 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D013211Q000187 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D015599 http://id.nlm.nih.gov/mesh/D012837Q000008 http://id.nlm.nih.gov/mesh/D051381 http://id.nlm.nih.gov/mesh/D016712Q000008 http://id.nlm.nih.gov/mesh/D000891Q000008 http://id.nlm.nih.gov/mesh/D000287 http://id.nlm.nih.gov/mesh/D005672Q000008 http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3000226 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7127 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID452254 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5215 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6087 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446596 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31011 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5459124 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441244

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136160078 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128600780 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129139087 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129223334

Total number of triples: 65.